Dermatology firms combine - St. Louis Business Journal:

zuloraxelewo.blogspot.com
Coral Gables-based Stiefel, a pharmaceutical company specializingin dermatology, said shares in Palo Alto, Calif.-based Connetics formerly tradedc under the "CNCT" ticker. The companies' combination unitesd Stiefel's skin care products and commercial capabilitieawith Connetics' therapies and patented drug-delivery technologies, includinhg foam-based items. "It results in one of the most robusty and diverse dermatology product lines in the industry and reinforcesz the commitment of Stiefekl Laboratories to the advancement ofdermatology globally," the localo company said.
"This mergee also creates one of the largest dermatologyy product pipelines inthe world, merging technologg and development expertise to yield significant advancementws in the treatment of skin conditions." Charles W. Stiefel, Stiefek chairman and chief executive said the deal helps his companty on its way to a goalof $1 billion in produc t sales. grand opening of a researcgh and development facility in ResearchTriangle Park, N.C. Some thingzs aren't planned to change. The global headquarters of Stiefek Laboratories is to remain in Coral Marketing and sales headquarteras are to remainin Ga.